Aktien in diesem Artikel
Indizes in diesem Artikel
For Immediate ReleaseChicago, IL – December 3, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Tesla
, Inc. TSLA, Meta Platforms
, Inc. FB, Abbott Laboratories
Corporation CMCSA and 3M Company MMM.Here are highlights from Thursday’s Analyst Blog:Top Analyst Reports for Tesla, Meta Platforms and Abbott LabsThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Tesla, Meta Platforms and Abbott Laboratories. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Shares of Tesla have outperformed the Zacks Domestic Automotive industry over the past year (+84.5% vs. +40.1%). The Zacks analyst believes that robust demand for Models 3 and Y has been buoying Tesla's revenues. Tesla achieved record production levels in the third quarter despite a chip crunch, on the back of robust demand for Model 3/Y cars.With China being the biggest EV market, TSLA is poised to witness strong revenues from its Shanghai factory in the quarters ahead. Production from Berlin and Texas gigafactories is also expected to commence this year. In addition to increasing automotive revenues, Tesla’s energy generation and storage revenues are also boosting earnings prospects.(You can read the full research report on Tesla here >>>)Meta Platforms shares have gained +14.7% in the year-to-date period against the S&P 500’s gain of +22.7%. The Zacks analyst, however, believes that Meta has been benefiting from steady user growth across all regions, particularly Asia-Pacific. Increased engagement for its products like Instagram, WhatsApp, Messenger and Meta Watch has been a major growth driver.FB’s focus on becoming a Metaverse company is noteworthy. Meta’s strong balance sheet and cash flow generating ability is a key catalyst. The tech giant, however, expects revenues to hurt from changes made by Apple in its iOS 14 update that limit its ability to track user-activity trends.(You can read the full research report on Meta Platforms here >>>)Shares of Abbott Laboratories have gained +19.7% in the last six months against the Zacks Medical Products industry’s gain of +8.5%. The Zacks analyst believes that strength in ABT’s branded generics and international diabetes businesses should drive growth in the coming quarters. New product launches and acquisitions is likely to boost sales further.Abbott posted better-than-expected earnings and revenue numbers for the third quarter of 2021. Barring Neuromodulation, the company registered organic sales growth across each of its operating segments. In Adult Nutrition, ABT reported robust global demand for Ensure and Glucerna. Slow growth in the nutrition business in China, however, continues to dampen the top-line growth.(You can read the full research report on Abbott Laboratories here >>>)Other noteworthy reports we are featuring today include Comcast and 3M.Media ContactZacks Investment Research800-767-3771 ext. email@example.com https://www.zacks.com Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Zacks' Top Picks to Cash in on Artificial Intelligence In 2021, this world-changing technology is projected to generate $327.5 billion in revenue. Now Shark Tank star and billionaire investor Mark Cuban says AI will create "the world's first trillionaires." Zacks' urgent special report reveals 3 AI picks investors need to know about today.See 3 Artificial Intelligence Stocks With Extreme Upside Potential>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report Comcast Corporation (CMCSA): Free Stock Analysis Report 3M Company (MMM): Free Stock Analysis Report Tesla, Inc. (TSLA): Free Stock Analysis Report Meta Platforms, Inc. (FB): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment ResearchWeiter zum vollständigen Artikel bei "Zacks"